fluorodopa f 18 has been researched along with Cacosmia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beuthien-Baumann, B; Kotzerke, J; Löhle, M; Oehme, L; Reichmann, H; Storch, A; van den Hoff, J; Wolz, M | 1 |
| Bressman, S; Brüggemann, N; Condefer, K; Dhawan, V; Hagenah, J; Klein, C; Kornreich, R; Ozelius, L; Palmese, C; Pastores, G; Roe, A; Sathe, S; Saunders-Pullman, R; Stanley, K; Tagliati, M | 1 |
2 other study(ies) available for fluorodopa f 18 and Cacosmia
| Article | Year |
|---|---|
Olfactory dysfunction correlates with putaminal dopamine turnover in early de novo Parkinson's disease.
Topics: Aged; Cohort Studies; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Female; Humans; Male; Middle Aged; Olfaction Disorders; Parkinson Disease; Positron-Emission Tomography; Putamen | 2020 |
Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization.
Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gaucher Disease; Glucosylceramidase; Humans; Male; Middle Aged; Mutation; Neuropsychological Tests; Olfaction Disorders; Parkinson Disease; Phenotype; Positron-Emission Tomography; Ultrasonography, Doppler, Transcranial | 2010 |